Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_assertion type Assertion NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_head.
- NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_assertion description "[These results represent the first demonstrations of functional activity of CFTR in the biosynthetic pathway and suggest that conformational changes in the mutant protein, although recognized by ER-retention mechanisms, do not necessarily affect CFTR chloride channel properties, which may have implications for pathophysiology and therapeutic interventions in cystic fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_provenance.
- NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_assertion evidence source_evidence_literature NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_provenance.
- NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_assertion SIO_000772 7539001 NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_provenance.
- NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_assertion wasDerivedFrom befree-2016 NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_provenance.
- NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_assertion wasGeneratedBy ECO_0000203 NP1311432.RAV1S2IKCBuZm3RrWiPajw3_G3z01rBOiFpTzaD6N9RI0130_provenance.